Esti Hendradi, Faddlun Nur Hidayati, Tristiana Erawati
Esti Hendradi*, Faddlun Nur Hidayati, Tristiana Erawati
Department of Pharmaceutics, Faculty of Pharmacy, Universitas Airlangga, Campus C Jl Mulyorejo-Surabaya 60115, Indonesia.
Volume - 14,
Issue - 3,
Year - 2021
The present study investigated the characteristics of diclofenac diethylammonium-containing NLC as function of ratio of glyceryl monostearate (GMS) and caprylic acid (mygliol 80) of 65:35; 75:25 and 85:15. There were three formulas and the composition of each formula were diclofenac diethylammonium 1.16%; glyceryl monostearate and caprylic acid with ratio (65:35; 75:25 and 85:15); Tween 80 5%; and phosphate buffer pH 6.0 ± 0.1 as dispersion medium. The result showed that each formula had different characteristic of particle size and efficiency entrapment. Particle size was analized by DelsaTMNano, F I (65:35) had particle size 134.467 ± 26.601 nm with PI 11.776; F II (75:25) had particle size 2252.233 ± 727.370 nm with PI 0.348; and F III (85:15) had particle size 1500.867 ± 219.673 nm with PI 0.260. The present Entrapment Efficiency (EE) carried out by centrifuge method and result of F I, F II and F III were 88.342 ± 0.52%, 73.764 ± 0.511% and 70.754 ± 0.665%, respectively. The result was analyzed by statistic with ANOVA one-way method with degree of confident 95% (a = 0.005). Research result revealed that the best characteristics of diclofenac diethylammonium in terms of particle size and % Entrapment Efficiency (EE) was F I with ratio of GMS and caprylic acid (mygliol 80) 65:35.
Cite this article:
Esti Hendradi, Faddlun Nur Hidayati, Tristiana Erawati. Characteristic of Nanostructured Lipid Carrier (NLC) Diclofenac Diethylammonium as Function of Ratio of Glyceryl Monostearate and Caprylic Acid. Research J. Pharm. and Tech 2021; 14(3):1699-1704. doi: 10.5958/0974-360X.2021.00302.4
Esti Hendradi, Faddlun Nur Hidayati, Tristiana Erawati. Characteristic of Nanostructured Lipid Carrier (NLC) Diclofenac Diethylammonium as Function of Ratio of Glyceryl Monostearate and Caprylic Acid. Research J. Pharm. and Tech 2021; 14(3):1699-1704. doi: 10.5958/0974-360X.2021.00302.4 Available on: https://rjptonline.org/AbstractView.aspx?PID=2021-14-3-91
1. Katzung BG, 2009. Basic and Clinical Pharmacology. 11th edition. China: The McGraw-Hill Companies, Inc. p. 636
2. Basri M, Abd Rahman RNZR, Ebrahimpour A, Salleh AB, Gunawan ER, Abd Rahman MB. Comparison of estimation capabilities of response surface methodology (RSM) with artificial neural network (ANN) in lipase-catalyzed synthesis of palm-based wax ester. BMC Biotechnol. 2007;7(1):53.
3. Kaim K. Incontinence Associated Dermatitis or Pressure Injury. Wound Manag Serv Gold Coast Univ Hosp. 2016;5.
4. Sweetman SC. Martindale: the complete drug reference. Vol. 3709. Pharmaceutical press London; 2009.
5. Silva NHCS, Rodrigues AF, Almeida IF, Costa PC, Rosado C, Neto CP, et al. Bacterial cellulose membranes as transdermal delivery systems for diclofenac: in vitro dissolution and permeation studies. Carbohydr Polym. 2014; 106:264–9.
6. Manosroi A, Jantrawut P, Manosroi J. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium. Int J Pharm. 2008 Aug;360(1-2):156–63.
7. Pathak Y, Thassu D. Drug delivery nanoparticles formulation and characterization. Vol. 191. CRC Press; 2016.
8. Williams A. Transdermal and topical drug delivery: from theory to clinical practice. Pharmaceutical Press London; 2003.
9. Hadgraft J, Plessis J du, Goosen C. The selection of non-steroidal anti-inflammatory agents for dermal delivery. Int J Pharm. 2000 Oct; 207(1-2):31–7.
10. Fini A, Bassini G, Monastero A, Cavallari C. Diclofenac Salts, VIII. Effect of the Counterions on the Permeation through Porcine Membrane from Aqueous Saturated Solutions. Pharmaceutics. 2012 Sep;4(3):413–29.
11. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S. Celecoxib nanoemulsion: skin permeation mechanism and bioavailability assessment. J Drug Target. 2008; 16(10):733–40.
12. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev. 2002 Nov;54: S131–55.
13. Tamjidi F, Shahedi M, Varshosaz J, Nasirpour A. Nanostructured lipid carriers (NLC): A potential delivery system for bioactive food molecules. Innov Food Sci Emerg Technol. 2013 Jul;19:29–43.
14. Müller RH, MaÈder K, Gohla S. Solid lipid nanoparticles (SLN) for controlled drug delivery–a review of the state of the art. Eur J Pharm Biopharm. 2000;50(1):161–77.
15. Chen-yu G, Chun-fen Y, Qi-lu L, Qi T, Yan-wei X, Wei-na L, et al. Development of a Quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 2012 Jul; 430(1-2): 292–8.
16. Hajare AA, Mali SS, Ahir AA, Thorat JD, Salunkhe SS, Nadaf SJ, et al. Lipid nanoparticles: A modern formulation approach in topical drug delivery systems. J Adv Drug Deliv. 2014; 1:30–7.
17. Dandagi PM, Dessai GA, Gadad AP, Desai VB. Formulation and evaluation of nanostructured lipid carrier (NLC) of lornoxicam. Int J Pharm Pharm Sci. 2014;6(2):73–7.
18. Khurana S, Jain NK, Bedi PMS. Development and characterization of a novel controlled release drug delivery system based on nanostructured lipid carriers gel for meloxicam. Life Sci. 2013 Nov;93(21):763–72.
19. Rowe RC, Sheskey P, Quinn M. Handbook of pharmaceutical excipients. Libros Digitales-Pharmaceutical Press; 2009.
20. Amelia P. Perbandingan Berbagai Jenis Pelarut Untuk Ekstraksi Daun Pandan Wangi (Pandanus amaryllifolius, Roxb) Terhadap Kualitas Hair Tonic Yang Dihasilkan. Universitas Andalas; 2016.
21. Commission BP. British pharmacopoeia. Station Off London UK. 2009;10181–6.
22. Bhaskar K, Anbu J, Ravichandiran V, Venkateswarlu V, Rao Y. Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies. Lipids Health Dis. 2009;8(1):6.